Ginkgo Bioworks Holdings Stock Total Asset
DNA Stock | USD 0.92 0.05 6.28% |
Ginkgo Bioworks Holdings fundamentals help investors to digest information that contributes to Ginkgo Bioworks' financial success or failures. It also enables traders to predict the movement of Ginkgo Stock. The fundamental analysis module provides a way to measure Ginkgo Bioworks' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Ginkgo Bioworks stock.
Last Reported | Projected for Next Year | ||
Total Assets | 1.7 B | 1.7 B | |
Intangibles To Total Assets | 0.08 | 0.08 |
Ginkgo | Total Asset |
Ginkgo Bioworks Holdings Company Total Asset Analysis
Ginkgo Bioworks' Total Asset is everything that a business owns. It is the sum of current and long-term assets owned by a firm at a given time. These assets are listed on a balance sheet and typically valued based on their purchasing prices, not the current market value.
Current Ginkgo Bioworks Total Asset | 1.67 B |
Most of Ginkgo Bioworks' fundamental indicators, such as Total Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Ginkgo Bioworks Holdings is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Ginkgo Total Asset Driver Correlations
Understanding the fundamental principles of building solid financial models for Ginkgo Bioworks is extremely important. It helps to project a fair market value of Ginkgo Stock properly, considering its historical fundamentals such as Total Asset. Since Ginkgo Bioworks' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Ginkgo Bioworks' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Ginkgo Bioworks' interrelated accounts and indicators.
Click cells to compare fundamentals
Ginkgo Total Asset Historical Pattern
Today, most investors in Ginkgo Bioworks Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Ginkgo Bioworks' growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's total asset growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Ginkgo Bioworks total asset as a starting point in their analysis.
Ginkgo Bioworks Total Asset |
Timeline |
Total Asset is typically divided on the balance sheet on current asset and long-term asset. Long-term is the value of company property and other capital assets that are expected to be useable for more than one year. Long term assets are reported net of depreciation. On the other hand current assets are assets that are expected to be sold or converted to cash as part of normal business operation.
Competition |
Ginkgo Total Assets
Total Assets |
|
Based on the latest financial disclosure, Ginkgo Bioworks Holdings has a Total Asset of 1.67 B. This is 77.85% lower than that of the Biotechnology sector and 15.72% lower than that of the Health Care industry. The total asset for all United States stocks is 94.35% higher than that of the company.
Ginkgo Total Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Ginkgo Bioworks' direct or indirect competition against its Total Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Ginkgo Bioworks could also be used in its relative valuation, which is a method of valuing Ginkgo Bioworks by comparing valuation metrics of similar companies.Ginkgo Bioworks is currently under evaluation in total asset category among related companies.
Ginkgo Bioworks Institutional Holders
Institutional Holdings refers to the ownership stake in Ginkgo Bioworks that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Ginkgo Bioworks' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Ginkgo Bioworks' value.Shares | Geode Capital Management, Llc | 2023-12-31 | 21.1 M | Norges Bank | 2023-12-31 | 14.8 M | Millennium Management Llc | 2023-12-31 | 9.3 M | Exor Investments (uk) Llp | 2023-12-31 | 8.5 M | Charles Schwab Investment Management Inc | 2023-12-31 | 7.7 M | Welch & Forbes Llc | 2023-12-31 | 7 M | Northern Trust Corp | 2023-12-31 | 6.1 M | Citadel Advisors Llc | 2023-09-30 | 5.2 M | Susquehanna International Group, Llp | 2023-12-31 | 4.9 M | Baillie Gifford & Co Limited. | 2023-12-31 | 236.3 M | Ark Investment Management Llc | 2023-12-31 | 198.6 M |
Ginkgo Fundamentals
Return On Equity | -0.63 | ||||
Return On Asset | -0.22 | ||||
Operating Margin | (5.16) % | ||||
Current Valuation | 1.04 B | ||||
Shares Outstanding | 1.65 B | ||||
Shares Owned By Insiders | 6.70 % | ||||
Shares Owned By Institutions | 83.98 % | ||||
Number Of Shares Shorted | 270.83 M | ||||
Price To Earning | 25.51 X | ||||
Price To Book | 1.98 X | ||||
Price To Sales | 8.65 X | ||||
Revenue | 251.46 M | ||||
Gross Profit | 273.49 M | ||||
EBITDA | (600.68 M) | ||||
Net Income | (892.87 M) | ||||
Cash And Equivalents | 1.32 B | ||||
Cash Per Share | 0.84 X | ||||
Total Debt | 241.77 M | ||||
Debt To Equity | 0.03 % | ||||
Current Ratio | 11.84 X | ||||
Book Value Per Share | 0.55 X | ||||
Cash Flow From Operations | (295.5 M) | ||||
Short Ratio | 11.02 X | ||||
Earnings Per Share | (0.46) X | ||||
Target Price | 1.97 | ||||
Number Of Employees | 1.22 K | ||||
Beta | 1.36 | ||||
Market Capitalization | 1.88 B | ||||
Total Asset | 1.67 B | ||||
Retained Earnings | (5.29 B) | ||||
Working Capital | 837.89 M | ||||
Current Asset | 10.07 B | ||||
Current Liabilities | 3.1 B | ||||
Net Asset | 1.67 B |
About Ginkgo Bioworks Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Ginkgo Bioworks Holdings's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Ginkgo Bioworks using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Ginkgo Bioworks Holdings based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Ginkgo Bioworks
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Ginkgo Bioworks position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ginkgo Bioworks will appreciate offsetting losses from the drop in the long position's value.Moving against Ginkgo Stock
0.59 | NUVB | Nuvation Bio Financial Report 2nd of May 2024 | PairCorr |
0.53 | MRKR | Marker Therapeutics | PairCorr |
0.41 | IMMP | Immutep Ltd ADR | PairCorr |
The ability to find closely correlated positions to Ginkgo Bioworks could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Ginkgo Bioworks when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Ginkgo Bioworks - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Ginkgo Bioworks Holdings to buy it.
The correlation of Ginkgo Bioworks is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Ginkgo Bioworks moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Ginkgo Bioworks Holdings moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Ginkgo Bioworks can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Ginkgo Bioworks Piotroski F Score and Ginkgo Bioworks Altman Z Score analysis. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Complementary Tools for Ginkgo Stock analysis
When running Ginkgo Bioworks' price analysis, check to measure Ginkgo Bioworks' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ginkgo Bioworks is operating at the current time. Most of Ginkgo Bioworks' value examination focuses on studying past and present price action to predict the probability of Ginkgo Bioworks' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ginkgo Bioworks' price. Additionally, you may evaluate how the addition of Ginkgo Bioworks to your portfolios can decrease your overall portfolio volatility.
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
AI Investment Finder Use AI to screen and filter profitable investment opportunities | |
Transaction History View history of all your transactions and understand their impact on performance | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals |
Is Ginkgo Bioworks' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ginkgo Bioworks. If investors know Ginkgo will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ginkgo Bioworks listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.46) | Revenue Per Share 0.129 | Quarterly Revenue Growth (0.65) | Return On Assets (0.22) | Return On Equity (0.63) |
The market value of Ginkgo Bioworks Holdings is measured differently than its book value, which is the value of Ginkgo that is recorded on the company's balance sheet. Investors also form their own opinion of Ginkgo Bioworks' value that differs from its market value or its book value, called intrinsic value, which is Ginkgo Bioworks' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ginkgo Bioworks' market value can be influenced by many factors that don't directly affect Ginkgo Bioworks' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Ginkgo Bioworks' value and its price as these two are different measures arrived at by different means. Investors typically determine if Ginkgo Bioworks is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ginkgo Bioworks' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.